Phase Ii Study Of Clinical Activity And Proteomic Profiling Of The Vegfr2 Inhibitor Vandetanib In Women With Relapsed Or Refractory Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
CANCER RESEARCH（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要